SectorPharmaceutical
Established Date28/07/2006
Listing Date18/02/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees191
Fiscal Year Ends31/12
Security TypeCommon stock
Office address389 Interpace Pkwy, Suite 450, Parsippany, NJ 07054
Business
IntroductionCorMedix Inc., was incorporated in Delaware on July 28, 2006. The Company is a biopharmaceutical company focused on the development and commercialization of therapeutic products for the prevention and treatment of life-threatening diseases and conditions. The company's main focus is the commercialization of its lead product, DefenCath, in the United States. The company has licensed the development and commercialization of DefenCath worldwide. The name DefenCath is an American proprietary name approved by the U.S. Food and Drug Administration (FDA).
